GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (OTCPK:ARSUF) » Definitions » Growth Rank

Fagron (Fagron) Growth Rank : 9 (As of May. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Fagron Growth Rank?

Fagron has the Growth Rank of 9.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Competitive Comparison of Fagron's Growth Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Fagron's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fagron's Growth Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fagron's Growth Rank distribution charts can be found below:

* The bar in red indicates where Fagron's Growth Rank falls into.



Fagron Growth Rank Related Terms

Thank you for viewing the detailed overview of Fagron's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Fagron (Fagron) Business Description

Traded in Other Exchanges
Address
Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies which are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America and Fagron Latin America. Majority of its revenue comes from Fagron EMEA.

Fagron (Fagron) Headlines

From GuruFocus

Q2 2022 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Full Year 2019 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2021 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2023 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2022 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Fagron NV At Capital Markets Day Transcript

By GuruFocus Research 02-12-2024

Q3 2019 Fagron NV Corporate Sales Call Transcript

By GuruFocus Research 02-12-2024

Q3 2023 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Q4 2022 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2023 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024